Professional
Added to YB: 2024-08-05
Pitch date: 2024-07-23
VEEV [bullish]
Veeva Systems Inc.
+19.95%
current return
Author Info
Ensemble Capital creates focused, fundamental-driven portfolios for private & institutional clients. Sign up for the newsletter.
Company Info
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Market Cap
$37.7B
Pitch Price
$186.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
32.89
P/E
44.67
EV/Sales
10.10
Sector
Health Care Technology
Category
growth
Veeva: A Winning Platform Strategy in Life Sciences
VEEV: Leading life sciences software co. 80% subscription rev, 20% services. 50% Commercial Solutions (CRM, marketing) & 50% R&D Solutions (clinical trials, regulatory). 94% biopharma, 4% medtech. $20B TAM, only 12% penetrated. Strong moat: 80%+ CRM share, integrated Vault platform. Headwinds: biopharma spend, AI eval. 3Y avg GAAP op margin tops peers. $2.4B FY24 rev. Risks: competition, spend slowdown.
Read full article (8 min)